Voyageur Pharmaceuticals Ltd

VM · V · Healthcare / Drug Manufacturers - Specialty & Generic

0.12CAD-0.01 (-7.69%)

Price History

Full chart

Market Stats

Previous Close0.13

Open0.13

Day Range0.12 – 0.13

52-Week Range0.07 – 0.195

Volume93.82K

Market Cap28.29M

P/E (TTM)0.00

Forward P/E0.00

EPS-0.02

Dividend Yield0.00%

Beta0.46

50-Day Avg0.1549

200-Day Avg0.1377

About

Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in acquiring, exploring, and developing raw materials for pharmaceutical products in the United States of America, the province of British Columbia, Canada, and the state of Utah. It develops barium and iodine-based APIs. The company offers Smooth HD, Smooth X, Smooth LD, Vision HD, Vision LD, V-Gas, and other products. The company has a collaboration with Bayer for the research and development of evaluating potential future production of iodine to be used in contrast media drugs. Voyageur Pharmaceuticals Ltd. was formerly known as Voyageur Minerals Ltd. and changed its name to Voyageur Pharmaceuticals Ltd. in December 2019. The company is headquartered in Calgary, Canada.

Company Details

SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
CEOMr. Brent Willis Bsc.Eng
Employees0
Headquarters4103 Centre Street NW, Calgary, AB, Canada, T2E 2Y6, Canada
Websitehttps://voyageurpharmaceuticals.ca

Leadership

Mr. Brent Willis Bsc.EngPresident, CEO & Director · b. 1971
Mr. Bradley Craig Willis P.Eng.Founder, COO & Director · b. 1971
Mr. Albert DeslauriersChief Financial Officer
Dr. Iryna Saranchova M.D., Ph.D.Chief Scientific Officer
Mr. Ethan MohanExecutive Vice President
Mr. Kyle PetersonHead of Regulatory Affairs
Dr. Ibrahim HashmiVice President of Business Development

Financials

Income Statement

Currency: CAD	2012-11-30	2013-11-30	2014-11-30	2015-11-30	2016-11-30	2017-11-30	2018-11-30	2019-11-30	2020-11-30	2021-11-30	2022-11-30	2023-11-30	2024-11-30	2025-11-30
Total Revenue	-	-	-	0	0	0	0	0	0	0	0	0	0	11.69K
Cost of Revenue	-	-	-	137.22K	113.54K	0	-	2.12K	1.48K	2.25K	2.91K	2.19K	0	11.69K
Gross Profit	-	-	-	-137.22K	-113.54K	0	-	-2.12K	-1.48K	-2.25K	-2.91K	-2.19K	0	0
Gross Margin	-	-	-	-	-	-	-	-	-	-	-	-	-	0.00%
Operating Expense	-	-	-	-135.74K	-61.21K	615.36K	-	552.77K	847.46K	2.05M	1.75M	1.34M	1.70M	3.53M
Operating Income	-85.52K	-45.33K	-94.46K	-1.48K	-52.32K	-615.36K	-866.03K	-554.89K	-848.94K	-2.05M	-1.75M	-1.35M	-1.70M	-3.53M
Operating Margin	-	-	-	-	-	-	-	-	-	-	-	-	-	-30231.56%
EBITDA	-85.52K	-45.33K	-94.46K	-1.48K	-52.32K	-615.36K	-1.15M	-552.77K	-847.46K	-2.05M	-1.74M	-1.34M	-1.70M	-3.53M
EBITDA Margin	-	-	-	-	-	-	-	-	-	-	-	-	-	-30221.87%
Net Income	-85.52K	-45.33K	-94.46K	-1.48K	-52.32K	-670.75K	-555.86K	-552.29K	-1.14M	-2.05M	-1.75M	-1.40M	-1.71M	-3.53M
Net Income Margin	-	-	-	-	-	-	-	-	-	-	-	-	-	-30231.56%
R&D	-	-	-	-	-	-	-	-	0	496.51K	527.56K	280.94K	287.44K	907.67K
R&D as % of Total Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	7767.80%
Interest Expense	-	-	-	0	0	0	0	0	18.65K	3.28K	0	4.48K	0	-

Balance Sheet

Currency: CAD	2011-11-30	2012-11-30	2013-11-30	2014-11-30	2015-11-30	2016-11-30	2017-11-30	2018-11-30	2019-11-30	2020-11-30	2021-11-30	2022-11-30	2023-11-30	2024-11-30	2025-11-30
Total Assets	206.21K	244.82K	184.60K	160.00K	89.36K	709.32K	869.88K	1.27M	1.61M	1.28M	2.57M	2.10M	2.16M	2.60M	3.11M
Total Liabilities	21.21K	23.47K	8.58K	78.45K	9.28K	38.86K	959.12K	750.79K	852.69K	968.85K	660.64K	630.83K	727.88K	2.15M	1.85M
Total Equity	185.00K	221.34K	176.02K	81.56K	80.07K	670.46K	-89.24K	515.68K	754.09K	306.33K	1.91M	1.46M	1.44M	449.96K	1.25M
Cash	156.81K	238.39K	183.66K	160.00K	89.36K	696.99K	17.05K	146.92K	75.61K	2.97K	812.97K	31.56K	2.08K	165.57K	267.05K
Total Debt	-	-	-	-	-	-	49.87K	179.65K	138.63K	268.41K	42.08K	25.52K	40.00K	-	-
Net Debt	-156.81K	-238.39K	-183.66K	-160.00K	-89.36K	-696.99K	32.82K	32.73K	63.02K	265.44K	-770.89K	-6.04K	37.91K	-	-

Cash Flow

Currency: CAD	2011-11-30	2012-11-30	2013-11-30	2014-11-30	2015-11-30	2016-11-30	2017-11-30	2018-11-30	2019-11-30	2020-11-30	2021-11-30	2022-11-30	2023-11-30	2024-11-30	2025-11-30
Operating Cash Flow	-28.19K	2.32K	-54.73K	-23.66K	-70.65K	-35.07K	-624.24K	-490.45K	-637.81K	-272.19K	-1.65M	-1.72M	-991.25K	-302.29K	-2.89M
Investing Cash Flow	-	-	-	-	-41.00K	-823	-191.86K	-224.05K	-169.62K	-151.79K	-432.08K	-	-	-	-
Financing Cash Flow	185.00K	79.26K	-	-	85.96K	642.71K	831.55K	844.37K	736.12K	351.34K	2.90M	1.21M	1.14M	631.73K	3.26M
Capital Expenditure	0	0	0	0	42.25K	163.65K	532.98K	321.00K	1.83K	161.94K	432.08K	282.91K	174.72K	0	0
Free Cash Flow	-28.19K	2.32K	-54.73K	-23.66K	-112.90K	-198.72K	-1.16M	-811.45K	-639.64K	-434.13K	-2.09M	-2.00M	-1.17M	-302.29K	-2.89M
FCF to OCF	100.00%	100.00%	100.00%	100.00%	159.81%	566.64%	185.38%	165.45%	100.29%	159.49%	126.12%	116.46%	117.63%	100.00%	100.00%

Earnings

Report Date	Feb 28, 2017	May 31, 2017	Aug 31, 2017	Nov 30, 2017	Feb 28, 2018	May 31, 2018	Aug 31, 2018	Nov 30, 2018	Apr 24, 2019	Jul 26, 2019	Oct 29, 2019	Nov 30, 2019	Apr 29, 2020	Jul 23, 2020	Oct 30, 2020	Nov 30, 2020	Apr 28, 2021	Jul 26, 2021	Oct 28, 2021	Nov 30, 2021	Mar 17, 2022	Aug 1, 2022	Oct 31, 2022	Nov 30, 2022	Apr 28, 2023	Jul 30, 2023	Oct 26, 2026
EPS Estimate	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EPS Actual	-0.00	-0.01	-0.01	-0.00	-0.00	-0.00	0.00	-0.01	-0.00	-0.00	-0.00	-0.00	-0.01	-0.00	-0.00	-0.00	-0.00	-0.00	-0.00	-0.01	-0.00	-0.00	-0.00	-0.01	-0.00	-0.00	-
Surprise	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Timing	-	-	-	-	-	-	-	-	After-hours	After-hours	After-hours	-	After-hours	After-hours	After-hours	-	After-hours	After-hours	After-hours	-	After-hours	After-hours	After-hours	-	After-hours	After-hours	After-hours

Key Statistics & Ratios

Market Cap28.29M

Enterprise Value33.55M

Trailing P/E0.00

Forward P/E0.00

Price / Sales598.93

Price / Book83.17

EPS-0.02

Book Value0.004

Revenue (TTM)47.24K

Gross Profit (TTM)0

EBITDA-3.30M

Profit Margin0.00%

Operating Margin-5312.69%

Return on Equity-574.21%

Return on Assets-66.85%

Shares Outstanding226.34M

Shares Float209.24M

Beta0.46

Dividend Yield0.00%

Dividend Rate0.00

Payout Ratio0.00%

Stock Splits

Mar 7, 20171:2